|
UBL3 expression based on
|
| Comparison | Statistical significance |
| Normal-vs-Primary | 8.781800E-02 |
|
Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
4.192200E-01 |
| Normal-vs-Stage2 |
1.328170E-01 |
| Normal-vs-Stage3 |
1.699730E-02 |
| Normal-vs-Stage4 |
4.780800E-03 |
| Stage1-vs-Stage2 |
3.691400E-01 |
| Stage1-vs-Stage3 |
4.529900E-02 |
| Stage1-vs-Stage4 |
2.746100E-02 |
| Stage2-vs-Stage3 |
6.340400E-01 |
| Stage2-vs-Stage4 |
2.525200E-01 |
| Stage3-vs-Stage4 |
3.956800E-01 |
|
|
Note
Patient race information is not available for 92 samples and one samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
1.319920E-02 |
| Normal-vs-AfricanAmerican |
6.215600E-01 |
| Normal-vs-Asian |
9.380200E-01 |
| Caucasian-vs-AfricanAmerican |
4.424400E-02 |
| Caucasian-vs-Asian |
4.876300E-02 |
| AfricanAmerican-vs-Asian |
6.584600E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
9.303800E-02 |
| Normal-vs-Female |
1.265580E-01 |
| Male-vs-Female |
6.165200E-01 |
|
|
Note
Seventeen samples from patient below 21 years not considered in above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
8.350800E-01 |
| Normal-vs-Age(41-60Yrs) |
7.107500E-02 |
| Normal-vs-Age(61-80Yrs) |
2.738500E-03 |
| Normal-vs-Age(81-100Yrs) |
7.584800E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
8.716500E-02 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
2.044100E-03 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
7.923000E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
9.878300E-02 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
9.547000E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
7.203800E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Classical-VS-Tall |
4.243200E-03 |
| Classical-VS-Follicular |
3.912200E-01 |
| Classical-VS-Other |
8.730000E-01 |
| Classical-VS-Normal |
2.049400E-01 |
| Tall-VS-Follicular |
4.124900E-03 |
| Tall-VS-Other |
2.306400E-01 |
| Tall-VS-Normal |
1.135670E-03 |
| Follicular-VS-Other |
6.919400E-01 |
| Follicular-VS-Normal |
8.616800E-01 |
| Other-VS-Normal |
4.782600E-01 |
|
|
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 50 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
1.598620E-01 |
| Normal-vs-N1 |
1.774110E-02 |
| N0-vs-N1 |
2.165400E-01 |
|
|
